NEW YORK, Feb 1 (Reuters) - Mylan Laboratories Inc. said on Thursday that quarterly profit more than doubled, and reported better-than-expected sales, helped by its generic version of the Ditropan XL ...

NEW YORK (Reuters) - Mylan Laboratories Inc. said on Thursday that quarterly profit more than doubled, helped by sales of its generic version of the Ditropan XL overactive bladder drug and fentanyl ...

Case Name: Bausch Health Ireland Ltd. v. Mylan Labs. Ltd., No. 21-10403 (SRC) (JSA), 2022 WL 683084 (D.N.J. Mar. 8, 2022) (Chesler, J.) Drug Product and Patent(s)-in ...

Billionaire investor Carl Icahn has dropped his $5.39 billion offer to buy Mylan Laboratories Inc. and tendered his shares after regulators opened an investigation of a Mylan pain patch that was ...

NEW YORK (MarketWatch) -- Mylan Laboratories Inc. said the Food and Drug Administration approved Mylan Pharmaceuticals's Abbreviated New Drug Application for a generic version of Pfizer's Accuretic ...

SAN FRANCISCO (MarketWatch) -- Mylan Laboratories Inc. and Forest Laboratories Inc.'s Forest Laboratories Holdings Ltd. said late Wednesday they have entered into an agreement for the ...